Loading clinical trials...
Loading clinical trials...
Study of the Progression of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Patients With Parkinson's Disease Divided Into Brain-first and Body-first Phenotypes
Conditions
Interventions
Clinical assessments
Phenotypic classification
Locations
1
Italy
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
Start Date
September 4, 2024
Primary Completion Date
October 30, 2025
Completion Date
May 1, 2031
Last Updated
April 23, 2026
NCT04876339
NCT06692920
NCT04246437
NCT06113640
NCT05508789
NCT05720468
Lead Sponsor
Azienda USL Reggio Emilia - IRCCS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions